Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
EAGLE PHARMACEUTICALS, INC. (EGRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 05/02/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 03/07/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/05/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/02/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 02/28/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 02/26/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/15/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 11/30/2016 |
10-K/A
| Annual Report for the period ended December 31, 2015 [amend] |
| 04/29/2016 |
10-K/A
| Annual Report for the period ended December 31, 2015 [amend] |
| 02/29/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 01/28/2015 |
10-K/A
| Annual Report for the period ended September 30, 2014 [amend] |
| 12/22/2014 |
10-K
| Annual Report for the period ended September 30, 2014 |
|
|